Richard A. Larson to Patient Compliance
This is a "connection" page, showing publications Richard A. Larson has written about Patient Compliance.
Connection Strength
0.067
-
Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study. Cancer Chemother Pharmacol. 2006 Jan; 57(2):199-206.
Score: 0.060
-
Evaluation of a potential enantioselective interaction between ticlopidine and warfarin in chronically anticoagulated patients. Ther Drug Monit. 1995 Feb; 17(1):33-8.
Score: 0.007